Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.58 - $7.34 $284,189 - $455,447
-62,050 Reduced 2.66%
2,273,894 $13 Million
Q4 2022

Feb 14, 2023

SELL
$4.61 - $8.5 $307,261 - $566,533
-66,651 Reduced 2.77%
2,335,944 $14.1 Million
Q3 2022

Nov 14, 2022

SELL
$5.0 - $8.82 $89,660 - $158,160
-17,932 Reduced 0.74%
2,402,595 $15.9 Million
Q2 2022

Aug 12, 2022

SELL
$4.0 - $7.55 $7,200 - $13,590
-1,800 Reduced 0.07%
2,420,527 $12.6 Million
Q1 2022

May 16, 2022

BUY
$6.9 - $13.22 $6.27 Million - $12 Million
908,641 Added 60.03%
2,422,327 $16.7 Million
Q4 2021

Feb 14, 2022

BUY
$11.89 - $31.74 $361,063 - $963,848
30,367 Added 2.05%
1,513,686 $18.8 Million
Q3 2021

Nov 15, 2021

BUY
$25.78 - $38.65 $5.04 Million - $7.56 Million
195,584 Added 15.19%
1,483,319 $46.4 Million
Q2 2021

Aug 16, 2021

BUY
$28.63 - $44.3 $18.5 Million - $28.6 Million
644,756 Added 100.28%
1,287,735 $36.9 Million
Q1 2021

May 14, 2021

BUY
$39.27 - $91.68 $4.99 Million - $11.6 Million
126,950 Added 24.6%
642,979 $27.9 Million
Q4 2020

Mar 01, 2021

SELL
$28.81 - $88.94 $6.06 Million - $18.7 Million
-210,434 Reduced 28.97%
516,029 $36.9 Million
Q3 2020

Nov 13, 2020

BUY
$26.2 - $30.13 $19 Million - $21.9 Million
726,463 New
726,463 $21.9 Million

Others Institutions Holding PRLD

About Prelude Therapeutics Inc


  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $47.3M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.